Molecular pharmacology of cell signling
-
Upload
aumnmumu-alshaty -
Category
Health & Medicine
-
view
293 -
download
4
description
Transcript of Molecular pharmacology of cell signling
![Page 1: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/1.jpg)
Molecular Pharmacology of
Cell Signaling
Mohanad AlBayati Mohanad AbdulSattar Ali Al-Bayati, BVM&S, MSc. Physiol., PhD.
Assistant Professor of Pharmacology and ToxicologyDepartment of Physiology and Pharmacology
College of Veterinary MedicineUniversity of Baghdad
Al Ameria, Baghdad Phone: 0964 7802120391
E. Mail: [email protected]@yahoo.com
![Page 2: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/2.jpg)
Previous soundness of drug cell signal
• What is cell signaling?• Signal transduction• Receptors• Types• Functions• Steps for signaling
![Page 3: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/3.jpg)
![Page 4: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/4.jpg)
![Page 5: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/5.jpg)
- Guanlyl cyclase activity
![Page 6: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/6.jpg)
![Page 7: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/7.jpg)
Receptors
Receptors are the sites at which biomolecules such as
hormones, neurotransmitters and the molecules responsible
for taste and odour are recognised.
A drug that binds to a receptor can either:
• Trigger the same events as the native ligand - an agonist.
Or
• Stop the binding of the native agent without eliciting a
response - an antagonist.
There are four ‘superfamilies’ of receptors.
![Page 8: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/8.jpg)
• Type 1. These have 4 or 5 membrane-spanning helical subunits. Their N- and C-terminii are found in the extracellular fluid. This family includes ion channels.
• Type 2. These have 7 helical transmembrane regions. Their N- terminal is extracellular and the C-terminal in intracellular. This family is coupled to the action of G-proteins: They are known as the G-protein coupled receptors.
• Type 3. These are tyrosine kinase-linked receptors with a single transmembrane helix. The insulin and growth factor receptors fall within this family.
• Type 4. These receptors are found in the cell nucleus and are transcription factors. They have looped regions held together by a group of four cysteine residues coordinating to a zinc ion. These motifs are called zinc fingers. The receptor ligands include steroids and thyroid hormones.
Receptors
![Page 9: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/9.jpg)
Today soundness of drug cell signal
What is G protein coupled receptor
RegulationWhat is G proteinRegulationMode of action
![Page 10: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/10.jpg)
![Page 11: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/11.jpg)
Signal Reception: G Protein-Coupled Receptors
![Page 12: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/12.jpg)
G-protein-Coupled Receptors may dimerize or form oligomeric complexes within the membrane.
Ligand binding may promote oligomerization, which may in turn affect activity of the receptor.
Various GPCR-interacting proteins (GIPs) modulate receptor function. Effects of GIPs may include: altered ligand affinity receptor dimerization or oligomerization control of receptor localization, including transfer to
or removal from the plasma membrane promoting close association with other signal proteins
![Page 13: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/13.jpg)
Neurotransmitter receptorsLigand – gated channels:
• Nicotinic acetylcholine receptor• NMDA-type glutamate receptor• Glycine receptor• GABAA receptor• Serotonin receptor (5-HT3)
G protein-coupled receptors:• Muscarinic acetylcholine receptor (several types)• Catecholamine receptors • Histamine receptors (H1, H2)• 5-HT receptors other than 5-HT3
• GABAB receptors• ‘Metabotropic’ glutamate receptors• Peptide receptors (Endorphin, cholecystokinin..)
![Page 14: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/14.jpg)
![Page 15: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/15.jpg)
![Page 16: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/16.jpg)
![Page 17: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/17.jpg)
![Page 18: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/18.jpg)
![Page 19: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/19.jpg)
![Page 20: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/20.jpg)
![Page 21: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/21.jpg)
![Page 22: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/22.jpg)
![Page 23: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/23.jpg)
`
![Page 24: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/24.jpg)
![Page 25: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/25.jpg)
![Page 26: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/26.jpg)
![Page 27: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/27.jpg)
![Page 28: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/28.jpg)
![Page 29: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/29.jpg)
![Page 30: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/30.jpg)
![Page 31: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/31.jpg)
![Page 32: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/32.jpg)
![Page 33: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/33.jpg)
![Page 34: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/34.jpg)
![Page 35: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/35.jpg)
![Page 36: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/36.jpg)
![Page 37: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/37.jpg)
![Page 38: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/38.jpg)
![Page 39: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/39.jpg)
![Page 40: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/40.jpg)
![Page 41: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/41.jpg)
![Page 42: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/42.jpg)
![Page 43: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/43.jpg)
Into nucleus
![Page 44: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/44.jpg)
![Page 45: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/45.jpg)
![Page 46: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/46.jpg)
Thanks
![Page 47: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/47.jpg)
The G Protein-Coupled Receptor (GPCR) Superfamily
• Largest known receptor family –
Constitutes > 1% of the genome.• Comprises receptors for a diverse array of molecules:
neurotransmitters, odorants, lipids, neuropeptides, large glycoprotein hormones.
• Odorant receptor family alone contains hundreds of genes.
• Mammalian GPCRs: nearly 300 different kinds – grouped into 3 main subfamilies:
![Page 48: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/48.jpg)
• Each GPCR family contains some orphan receptors, which have been identified as members of the GPCR superfamily by homology cloning but whose activating ligand is unknown.
• But high throughput screening has recently added to the advances in being able to identify the ligand.
![Page 49: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/49.jpg)
• GPCRs Interact guanine nucleotide-binding proteins (aka G-proteins)
• Largest family of membrane proteins in the human genome
• Eukaryotic trans membrane receptors• Seven helices spanning the membrane
![Page 50: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/50.jpg)
Roles: - Light and smell processing
- Behavior and mood - Immune response - Autonomic nervous system transmission - Blood pressure - Heart rate - Digestive processes - CRITICAL FACTOR IN MANY DISEASES!
![Page 51: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/51.jpg)
Five different classes (based on sequence and function):
- Class A: Rhodopsin-like receptors - Class B: Secretin receptor family - Class C: Metabotropic glutamate/pheromone - Class D: Fungal pheromone receptors - Class E: Cyclyic AMP receptors
![Page 52: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/52.jpg)
Almost all Receptors Comprise a Number of Subtypes
• Dopamine receptors - 5 subtypes• 5-HT receptors – 13 subtypes• mGlu receptors - 8 subtypes• Acetylcholine receptors – 5 subtypes• Identified by their pharmacological and functional
characteristics, rather than by strict sequence homology:
- Some receptors for the same ligand show remarkably little homology (e.g., histamine H3 and H4 have the lowest recorded homology (~ 20 %) to other histamine receptors H1 and H2).
![Page 53: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/53.jpg)
![Page 54: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/54.jpg)
Regulation of G protein-coupled receptor function
Desensitization/resensitization– a decrease in responsiveness during continuous drug application or a right-shift in a drug dose-response curve.
After removal of the drug, receptor activity recovers, although the speed and extent of this resensitization can depend on the duration of agonist activation.
Rapid desensitization (sec-min) results from receptor phos, arrestin binding, and receptor internalization.
Long-term desensitization (down-regulation) involve changes in receptor and/or G protein levels, and their mRNA stability and expression.
Long-term changes in [GPCR]s and [accessory proteins]s known to be induced by chronic drug treatment and involved in several pathologies.
![Page 55: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/55.jpg)
Phosphorylation2nd messenger kinaseG protein receptor kinase (GRK)Arrestinβ-arrestin binding to phosphorylated GPCR is
required to decrease GTPase activity prior to desensitization.
Receptor trafficking, internalization, and recycling (covered earlier; see Protein trafficking and LGIC slides).
![Page 56: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/56.jpg)
Mechanisms of long-term down regulationLong-term (> 1 hr) treatment with agonist induces the loss of total
cellular receptor number in addition to the decr in surface receptor number.
e.g., antidepressants (e.g., fluoxetine) incr [5HT]synapse decr 5HT receptor density.
Receptor endocytosis: C-terminal domain determines whether they enter the recycle pathway or the lysosomal pathway:
- 2 distinct motifs: 1. PDZ-domain interats with NHERF in a phos-dependent manner.
2. A short sequence that interacts with NSF (N-ethylmaleimide sensitive factor).
Arrestin has also been shown to be important for recycling:e.g., V2 vasopressin receptor, which continues to bind arrestin
while in endosomes, does not recycle back to plasma membrane.
![Page 57: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/57.jpg)
D D D D
αα
βα γ
(1) Agonist bindingand G protein
activation
(2) Phosphorylation
P P
(3) Arrestinbinding
ArrestinP P
ArrestinP P
Clathrin(4) Clustering inclathrin-coated
pits
(5) EndocytosisEndosomes
ArrestinP P
D
(7) Recycling
(6) Dissociation of agonist:• Dephosphorylation• Sorting between cycling
and lysosomal pathways
(8) Traffic tolysosomes
Lysosomes
Mechanisms of Receptor Regulation
![Page 58: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/58.jpg)
Another Receptor – G Protein Cycle
![Page 59: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/59.jpg)
Structure, function and mechanisms of G-Proteins
![Page 60: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/60.jpg)
What are G-proteins?• G proteins bind GTP: guanosine triphosphate. Control and amplify
intracellular signaling pathways
Exist in two states 1) bound GTP: active2) bound GDP: inactive
Fig. 15.1
Examples of GTPase proteinsRas, Cdc-42
(hormone, GF, drug)
![Page 61: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/61.jpg)
1994 Nobel Prize in Medicine, Alfred Gilman and Martin Rodbell, for their „discovery of G-Proteinsand the role of these proteins in signal transduction in cells.“
![Page 62: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/62.jpg)
G-Protein = Guanine-nucleotide binding protein(GNBD)
12
5
43
Guanine
Ribose
Phosphates
α
1
3
42
65 7
89
Guanosine
EsterAnhydride
Guanosine-triphosphate - GTP
![Page 63: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/63.jpg)
G-Protein families• Heterotrimeric G-Proteins (Transducin, Gi, Gq …), in 7-
TM receptor signalling• Initiation, elongation, termination factors in protein
synthesis (IF1, EF-Tu, EF-TS) • Signal recognition particle (SRP) and its receptor,
translocation of nascent polypeptide chains in the ER• Ras-like GTPases (Ras, Rap, Rho, Ran, Rab, Arf, Arl, Sar),
molecular switches in signal transduction• Dynamin superfamily of GTPases, remodelling of
membranes + 60 further distinct families
Leipe et al., JMB (2002)
![Page 64: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/64.jpg)
GTPases and disease.
• Damage to these small GTPase switches can have catastrophic consequences for the cell and the organism.
• Several small GTPases of the Rac/Rho subfamily are direct targets for clostridial cytotoxins.
• Further, Ras proteins are mutated to a constitutively-active (GTP-bound) form in approximately 20% of human cancers.
![Page 65: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/65.jpg)
G-proteins are tightly regulated
3 types of accessory proteins that modulate cycling of G-proteins between GTP/GDP
1. GAPs: GTPase-activating proteins. Stimulate GTP hydrolysis. Inactivate G-protein. Example of a GAP: PLC .b
2. GEFs: Guanine nucleotide-exchange factors: G-protein-coupled receptors (GPCR). Stimulate dissociation of GDP (inactive) from G-protein so GTP can bind (active).
3. GDIs: Guanine nucleotide-dissociation inhibitors. Inhibit release of bound GDP (maintain G-protein in inactive state).
![Page 66: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/66.jpg)
The heterotrimeric G proteins transmit signals from a variety of cell surface receptors to enzymes and channels
• Stimulated by receptors• Act on effectors• Regulated by nucleotide
exchange and hydrolysis
![Page 67: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/67.jpg)
The signal is usually passed from a 7-helix receptor to an intracellular G-protein. Seven-helix receptors are thus called
GPCR, or G-Protein-Coupled Receptors.
Approx. 800 different GPCRs are encoded in the human genome.
![Page 68: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/68.jpg)
G-proteins are heterotrimeric, with 3 subunits a, b, g.
A G-protein that activates cyclic-AMP formation within a cell is called a stimulatory G-protein, designated Gs with alpha subunit Gsa.
Gs is activated, e.g., by receptors for the hormones epinephrine and glucagon.
The b-adrenergic receptor is the GPCR for epinephrine.
![Page 69: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/69.jpg)
These domains include residues adjacent to the terminal phosphate of GTP and/or the Mg++ associated with the two terminal phosphates.
Inhibitory G
GTPS
PDB 1GIA Structure of G proteins:
The nucleotide binding site in Ga consists of loops that extend out from the edge of a 6-stranded b-sheet.
Three switch domains have been identified, that change position when GTP substitutes for GDP on Ga.
![Page 70: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/70.jpg)
GTP hydrolysis occurs by nucleophilic attack of a water molecule on the terminal phosphate of GTP.
Switch domain II of Ga includes a conserved glutamine residue that helps to position the attacking water molecule adjacent to GTP at the active site.
O
OHOH
HH
H
CH2
H
OPOPOP O
O
O O
O O
O
NH2
NH
NN
N
O
H O
H
GTP hydrolysis
![Page 71: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/71.jpg)
The b subunit of the heterotrimeric G Protein has a b-propeller structure, formed from multiple repeats of a sequence called the WD-repeat. The b-propeller provides a stable structural support for residues that bind Ga.It is a common structural motif for protein domains involved in protein-protein interaction.
G - side view of -propeller
PDB 1GP2
G – face view of -propeller
PDB 1GP2
![Page 72: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/72.jpg)
The family of heterotrimeric G proteins includes also: transducin, involved in sensing of light in the retina. G-proteins involved in odorant sensing in olfactory
neurons.
There is a larger family of small GTP-binding switch proteins, related to Ga.
![Page 73: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/73.jpg)
Small GTP-binding proteins include (roles indicated): initiation & elongation factors (protein synthesis). Ras (growth factor signal cascades). Rab (vesicle targeting and fusion). ARF (forming vesicle coatomer coats). Ran (transport of proteins into & out of the nucleus). Rho (regulation of actin cytoskeleton)
All GTP-binding proteins differ in conformation depending on whether GDP or GTP is present at their nucleotide binding site.
Generally, GTP binding induces the active state.
![Page 74: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/74.jpg)
A GAP may provide an essential active site residue, while promoting the correct positioning of the glutamine residue of the switch II domain. Frequently a (+) charged arginine residue of a GAP inserts into the active site and helps to stabilize the transition state by interacting with (-) charged O atoms of the terminal phosphate of GTP during hydrolysis.
Most GTP-binding proteins depend on helper proteins:
GAPs, GTPase Activating Proteins, promote GTP hydrolysis.
protein-GTP (active) GDP GEF GAP GTP Pi protein-GDP (inactive)
![Page 75: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/75.jpg)
Ga of a heterotrimeric G protein has innate capability for GTP hydrolysis.
It has the essential arginine residue normally provided by a GAP for small GTP-binding proteins.
However, RGS proteins, which are negative regulators of G protein signaling, stimulate GTP hydrolysis by Ga.
protein-GTP (active) GDP GEF GAP GTP Pi protein-GDP (inactive)
![Page 76: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/76.jpg)
An activated receptor (GPCR) normally serves as GEF for a heterotrimeric G-protein.
Alternatively, AGS (Activator of G-protein Signaling) proteins may activate some heterotrimeric G-proteins, independent of a receptor.
Some AGS proteins have GEF activity.
protein-GTP (active) GDP GEF GAP GTP Pi protein-GDP (inactive)
GEFs, Guanine Nucleotide Exchange Factors, promote GDP/GTP exchange.
![Page 77: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/77.jpg)
a & g subunits have covalently attached lipid anchors that bind a G-protein to the plasma membrane cytosolic surface.
Adenylate Cyclase (AC) is a transmembrane protein, with cytosolic domains forming the catalytic site.
AC
hormone signal outside GPCR plasma membrane
GTP GDP ATP cAMP + PP i
cytosol
GDP GTP
The asubunit of a G-protein (Ga) binds GTP, & can hydrolyze it to GDP + Pi.
![Page 78: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/78.jpg)
![Page 79: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/79.jpg)
The sequence of events by which a hormone activates cAMP signaling:
1. Initially Ga has bound GDP, and a,b, &g subunits are complexed together.
Gb,g, the complex of b & g subunits, inhibits Ga.
AC
hormone signal outside GPCR plasma membrane
GTP GDP ATP cAMP + PPi
cytosol
GDP GTP
![Page 80: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/80.jpg)
2. Hormone binding, usually to an extracellular domain of a 7-helix receptor (GPCR), causes a conformational change in the receptor that is transmitted to a G-protein on the cytosolic side of the membrane. The nucleotide-binding site on Ga becomes more accessible to the cytosol, where [GTP] > [GDP]. Ga releases GDP & binds GTP (GDP-GTP exchange).
AC
hormone signal outside GPCR plasma membrane
GTP GDP ATP cAMP + PP i
cytosol
GDP GTP
![Page 81: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/81.jpg)
3. Substitution of GTP for GDP causes another conformational change in Ga.
Ga-GTP dissociates from the inhibitory bg complex & can now bind to and activate Adenylate Cyclase.
AC
hormone signal outside GPCR plasma membrane
GTP GDP ATP cAMP + PP i
cytosol
GDP GTP
![Page 82: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/82.jpg)
Fig 15.3 The G Protein Cycle
![Page 83: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/83.jpg)
G P
rote
in-L
inke
d R
ecep
tors
![Page 84: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/84.jpg)
G P
rote
in-L
inke
d R
ecep
tors
![Page 85: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/85.jpg)
G P
rote
in-L
inke
d R
ecep
tors
![Page 86: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/86.jpg)
G P
rote
in-L
inke
d R
ecep
tors
note how activation is reversible
![Page 87: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/87.jpg)
G P
rote
in-L
inke
d R
ecep
tors
the more ligand binding, the more K+ in cytoplasm
![Page 88: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/88.jpg)
Regulation at the G protein levelRegulator of G protein signaling (RGS = GAPs = GTPase
activating proteins) family of proteins (> 20 members) regulate the rate of GTP hydrolysis in the Gα subunit.
Can also attenuate G protein actions that are mediated by βγ subunits, because they can alter the number of βγ available by enhancing the affinity of Gα subunits for the βγ after GTP hydrolysis incr rate of reformation of the heterotimer.
![Page 89: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/89.jpg)
Regulation at the G protein level (cont’d)RGS proteins also important in regulating the temporal
characteristics of G protein actions.E.g., RGS proteins accelerate the decay of agonist-
induced activation of GIRK (G protein regulated inward rectifying K channels).
E.g., RGS proteins accelerate desensitization of adrenergic receptor-induced N-type Ca2+ channel currents.
![Page 90: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/90.jpg)
• ADH - Promotes water retention by the kidneys (V2 Cells of Posterior Pituitary)
• GHRH - Stimulates the synthesis and release of GH (Somatotroph Cells of Anterior Pituitary)
• GHIH - Inhibits the synthesis and release of GH (Somatotroph Cells of Anterior Pituitary)
• CRH - Stimulates the synthesis and release of ACTH (Anterior Pituitary)
![Page 91: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/91.jpg)
• ACTH - Stimulates the synthesis and release of Cortisol (zona fasiculata of adrenal cortex in kidneys)
• TSH - Stimulates the synthesis and release of a majority of T4 (Thyroid Gland)
• LH - Stimulates follicular maturation and ovulation in women; Stimulates testosterone production and spermatogenesis in men
![Page 92: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/92.jpg)
• FSH - Stimulates follicular development in women; Stimulates spermatogenesis in men
• PTH - Increases blood calcium levels (PTH1 Receptor: Kidneys and Bone; PTH2 Receptor: Central Nervous system, Bones, Kidneys, Brain)
• Calcitonin - Decreases blood calcium levels (Calcitonin Receptor: Intestines, Bones, Kidneys, Brain)
• Glucagon - Stimulates glycogen breakdown (liver)• hCG - Promotes cellular differentiation; Potentially
involved in apoptosis
![Page 93: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/93.jpg)
bg
How G-protein-coupled receptors work (1)
a
extracellular space
cytosol
abg heterotrimeric G-protein
‘7TM’ - receptor
GDP
GDP
N
GTP
Ligand
![Page 94: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/94.jpg)
How G-protein-coupled receptors work (2)
inactive
abg
N
GDP
a
GTP
P
bg
N
active
![Page 95: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/95.jpg)
How G-protein-coupled receptors work (3)
ATP
inactive
inactive
activecAMP
cAMP
Protein kinase A
Phosphorylation of multiple target proteins
bg aGTP
active
Adenylate cyclase
![Page 96: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/96.jpg)
Some G-proteins are inhibitoryb-Adrenoceptor
a2-Adrenoceptor
as
GTP
ACactive
ACinactive
ai
GTP
![Page 97: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/97.jpg)
bg-Subunits of G proteins may have regulatory activity, too
K+
Muscarinic (M2)acetylcholine receptor
Kir
bg
ACinactive
ai
GTP
![Page 98: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/98.jpg)
Ga-proteins regulate diverse effector systems
asadenylate cyclase protein kinase AcAMP
ai1adenylate cyclase protein kinase AcAMP
aqphospholipase C
PIP2 IP3 + DAG protein kinase C
phosphorylation ofmultiple proteins
Ca++
ER
atcGMP phosphodiesterase cGMP
![Page 99: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/99.jpg)
Many transmitters have multiple GPCR with different downstream
signaling mechanismsNorepinephrine, a1 IP3 + DAG epinephrinea2 cAMP b1,b2 cAMP
Dopamine D2 - D4 cAMP D1, D5 cAMP
Acetylcholine M1,,M4,M5IP3 + DAG M2, M3 cAMP
![Page 100: Molecular pharmacology of cell signling](https://reader036.fdocuments.in/reader036/viewer/2022081507/554b0f29b4c9056f098b48d4/html5/thumbnails/100.jpg)
Thanks